SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2014 / Cilt: 23 - Sayı: 2

Cogan Sendromunda FDG-PET/BT nin Önemi

The Importance of FDG-PET/CT in Cogan's Syndrome

Aslı YILDIZ
Mahir UĞUR
Bedri SEVEN
Ebru ÖRSAL
Arif Kürşad AYAN
Fatma İÇYER
Pages
74–75
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hence, we can conclude that FDG-PET/CT may play an important role in excluding the presence of vasculitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The present study gives a detailed report of a patient with atypical Cogan s syndrome with uveitis and sensorineural hearing loss.
📊
Key Findings & Data:Cogan s syndrome is characterized by nonsyphilitic interstitial keratitis and audiovestibular dysfunction.
💡
Conclusion & Impact:Hence, we can conclude that FDG-PET/CT may play an important role in excluding the presence of vasculitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The present study gives a detailed report of a patient with atypical Cogan s syndrome with uveitis and sensorineural hearing loss. Cogan s syndrome is characterized by nonsyphilitic interstitial keratitis and audiovestibular dysfunction. This syndrome can be divided into two groups, typical and atypical, based on the presence of interstitial keratitis. It may sometimes be associated with systemic vasculitis. Fluoro-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) scanning was used to investigate the presence of vasculitis. With FDG-PET/CT scanning, there is no pathological involvement in the walls of the arteries; thus the patient is protected from aggressive and long term immunosuppressive treatment s side effects. Hence, we can conclude that FDG-PET/CT may play an important role in excluding the presence of vasculitis.

Özet

Çalışmamızda sensorinöral işitme kaybı ve üveiti olan atipik Cogan sendromlu bir hastayı detaylı bir şekilde ele aldık. Cogan sendromu nonsifilitik interstisyel keratit ve odiovestibuler disfonksiyon ile karakterize bir hastalıktır. Interstisyel keratitin varlığına göre Cogan sendromu tipik ve atipik olmak üzere iki gruba ayrılabilir. Bu sendroma bazen sistemik vaskülit eşlik edebilir. Fluoro-D-glucose-positron emission tomografi/bilgisayarlı tomografi (FDG-PET/BT) taraması sistemik vaskülit varlığının araştırılması amacı ile kullanılabilir. Bu amaçla hastaya yapılan FDG-PET/BT taraması ile arter duvarlarında patolojik bulgu saptanmadı. Böylece hasta uzun süreli ve agresif immünsüpresif tedavinin yan etkilerinden korunmuş oldu. Vaskülit varlığını dışlamada FDG-PET/BT taramasının önemli bir yeri olduğunu söyleyebiliriz.

🔖

Cite This Article

YILDIZ, A., UĞUR, M., SEVEN, B., ÖRSAL, E., AYAN, A. K., İÇYER, F. (2022). Cogan Sendromunda FDG-PET/BT nin Önemi. Molecular Imaging and Radionuclide Therapy, Cilt: 23 - Sayı: 2, 74–75. https://ajindex.com/articles/581636

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and vestibulo-auditory symptoms. Arch Ophthalmol 1945;33:144-149
  2. Gaubitz M, Lubben B, Seidel M, Schotte H, Gramley F, Domscheke W. Cogan’s syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol 2001;19:463-469
  3. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan’s syndrome: studies on thirteen patients, long-term follow up, and a review of the literature. Medicine (Baltimore) 1980;59:426-441
  4. Grasland A, Pouchot J, Hachulla E, Bletry O, Papo T, Vinceneux P; Study Group for Cogan’s Syndrome. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004;43:1007-1015
  5. Vollertsen RS, McDonald TJ, Younge BR, Banks PM, Stanson AW, Ilstrup DM. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986;61:344-361
  6. Pagnini I, Zannin ME, Vittadello F, Sari M, Simonini G, Cimaz R, Zulian F. Clinical Features and Outcome of Cogan Syndrome. J Pediatr 2012;160:303-307
  7. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N, Konishi J. Increased F18-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658-663
  8. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of 18F-FDG PET in the diagnosis of largevessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674-681
  9. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003;30:1305-1313
  10. Balink H, Bruyn GA. The role of PET/CT in Cogan’s syndrome. Clin Rheumatol 2007;26:2177-2179
  11. Allen NB, Cox CC, Cobo M, Kisslo J, Jacobs MR, McCallum RM, Haynes BF. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan’s Syndrome. Am J Med 1990;88:296-301.